News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aerocrine Enters Into a License Agreement With Medisoft


3/25/2013 9:36:51 AM

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B) today announced the signing of a license agreement with Medisoft S.A. The agreement includes the withdrawal of all patent proceedings between the companies. Medisoft has entered into a license agreement with Aerocrine under Aerocrine’s European Patents EP 0 606 351, EP 0724 723, EP 1439 781, EP 1661 514, EP 1 545 305, EP 0 973 444 and EP 0 892 926 and their respective Indian and Australian counterparts. The royalty bearing license grants Medisoft the right to manufacture its current HypAir FeNO, HypAir FeNO+ and HypAir NO Nasal products in Belgium and to sell the products in Europe, Australia and India under Aerocrine’s patents.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES